NIMENRIX 0.5 ML VIAL VACCINE

The NIMENRIX 0.5 ML VIAL VACCINE is a crucial immunization designed to protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y. This vaccine is widely available and recognized for its role in public health initiatives, often referenced on platforms like Nahdi Online for its significance in vaccination schedules.

Developed by Pfizer, NIMENRIX provides active immunization for individuals from 6 weeks of age and older. Its formulation ensures a robust immune response, helping to prevent serious conditions such as meningitis and sepsis.

Benefits of Use

• Provides broad protection against four major serogroups (A, C, W-135, Y) of meningococcal bacteria.
• Helps prevent life-threatening conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis (blood poisoning).
• Suitable for a wide age range, from infants (6 weeks) to adults.
• Contributes to community immunity, reducing the spread of meningococcal disease.

How to Use

1. NIMENRIX is administered as an intramuscular injection.
2. The vaccine should be given by a healthcare professional.
3. The specific dosing schedule depends on the age of the individual being vaccinated:
• For infants aged 6 weeks to 6 months, a primary series of two doses, followed by a booster dose, is typically recommended.
• For infants aged 6 months to 12 months, a single primary dose followed by a booster dose is usually sufficient.
• For children from 12 months of age, adolescents, and adults, a single dose is generally administered.
4. Always follow the instructions provided by your doctor or healthcare provider regarding the number of doses and timing.
5. Ensure the vaccine is visually inspected for particulate matter and discoloration prior to administration.

Caution & Warnings

• This vaccine is for intramuscular injection only. Do not administer intravenously, intradermally, or subcutaneously.
• Individuals with a known hypersensitivity to the active substances or to any of the excipients should not receive this vaccine.
• As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reaction following administration.
• NIMENRIX may not protect all vaccine recipients.
• Delay vaccination in persons suffering from acute severe febrile illness.
• Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
• Common side effects may include pain, redness, or swelling at the injection site, headache, fatigue, muscle aches, and fever.

Ingredients

Each 0.5 mL dose contains:

• Neisseria meningitidis serogroup A oligosaccharide (5 mcg) conjugated to tetanus toxoid (16.7-33.3 mcg)
• Neisseria meningitidis serogroup C oligosaccharide (5 mcg) conjugated to tetanus toxoid (16.7-33.3 mcg)
• Neisseria meningitidis serogroup W-135 oligosaccharide (5 mcg) conjugated to tetanus toxoid (16.7-33.3 mcg)
• Neisseria meningitidis serogroup Y oligosaccharide (5 mcg) conjugated to tetanus toxoid (16.7-33.3 mcg)
• Excipients: Sodium chloride, Water for injection.

Product Details

• Form: Solution for injection in a vial
• Strength: 0.5 ML per dose
• Administration Route: Intramuscular
• Manufacturer: Pfizer
• Storage Conditions: Store in a refrigerator (2°C - 8°C). Do not freeze. Keep the vial in the outer carton to protect from light.
• Package Type: Single dose vial